# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 11161
- **Admission ID**: 121167
- **Row ID**: 12349
- **Profile Type**: FULL

## Demographics

- **Age**: 81
- **Sex**: M
- **Date of Birth**: 2037-04-20
- **Ethnicity**: UNKNOWN/NOT SPECIFIED
- **Marital Status**: nan
- **Religion**: CATHOLIC
- **Insurance**: Medicare
- **Admission Type**: EMERGENCY
- **Admission Date**: 2119-03-08 18:36:00
- **Discharge Date**: 2119-03-26 16:26:00

## Chief Complaint

Shortness of breath.

## Symptoms

- **Shortness of breath**
- **Worsening shortness of breath and dyspnea** | onset: Three days prior to admission | duration: Three days
- **Scratchy throat** | onset: Three days prior to admission
- **Worsening cough productive of clear sputum** | onset: Three days prior to admission
- **Worsening leg swelling** | onset: Day of admission
- **Tachypnea** | onset: At outside hospital admission
- **ankle edema bilaterally**
- **dysphagia**
- **hyperkalemia** | onset: postoperative day nine
- **blood sugars ranging from 81 to 300**

## Medical History

Coronary artery disease status post myocardial infarction. Congestive heart failure with ejection fraction of 45%. Diabetes mellitus type II diagnosed 10 years ago. Spinal stenosis. Hypertension. Hypercholesterolemia. Nephrolithiasis. Osteoarthritis.

## Current Medications

- **Diamox** | dosage: 20 milligrams | frequency: po q day
- **Motrin** | dosage: 800 milligrams | frequency: po q day
- **Zantac** | dosage: 150 milligrams | frequency: po bid
- **Zestril** | dosage: 5 milligrams | frequency: po q day
- **Lipitor** | dosage: 10 milligrams | frequency: po q day
- **Sublingual nitroglycerin** | frequency: prn
- **Glucovance** | dosage: 5/500 | frequency: po bid
- **Imdur** | dosage: 60 milligrams | frequency: po bid
- **Atenolol** | dosage: 25 milligrams | frequency: po q day
- **Ecotrin** | dosage: 325 milligrams | frequency: po q day

## Discharge Medications

- **Lopressor** | dosage: 25 milligrams | frequency: po bid
- **Colace** | dosage: 100 milligrams | frequency: po bid
- **E-CASA** | dosage: 325 milligrams | frequency: po q day
- **Amiodarone** | dosage: 400 milligrams | frequency: po q day
- **Norvasc** | dosage: 7.5 milligrams | frequency: po q day
- **Combivent** | dosage: two puffs | frequency: q six hours
- **Protonix** | dosage: 40 milligrams | frequency: po q day
- **Glyburide** | dosage: 10 milligrams | frequency: po bid
- **Lantus insulin** | dosage: 14 units | frequency: q HS
- **Hydralazine** | dosage: 20 milligrams | frequency: po qid
- **Lasix** | dosage: 20 milligrams | frequency: po bid times seven days
- **KCL** | dosage: 20 milliequivalents | frequency: po q day times seven days
- **Humalog insulin sliding scale**
- **Florinef** | dosage: 0.1 milligrams | frequency: po q day
- **Tylenol #3** | dosage: one to two | frequency: po q every four hours prn

## Diagnoses

- **Congestive heart failure** | notes: Diagnosed at outside hospital; ejection fraction decreased to 30% with new anteroapical hypokinesis
- **three vessel coronary artery disease** | notes: LAD with 90% proximal lesion, left circumflex and right coronary artery occluded proximally
- **reduced ejection fraction (30%)** | notes: Echocardiogram showed hypokinesis of anteroapical and marked hypokinesis of inferior wall
- **atrial fibrillation (postoperative, rapid)** | notes: Occurred on postoperative day three, blood pressure stable
- **moderate oropharyngeal swallow dysfunction** | notes: No frank aspiration, significant for aspiration risk
- **left lower lobe consolidation** | notes: Noted on chest x-ray, question of aspiration
- Status post CABG times three
- Atrial fibrillation
- Dysphagia
- Diabetes mellitus
- Hypercholesterolemia

## Treatment Options

### Diuresis

**Details**: Diuresed with Lasix
**Treatment**: Lasix

**Medications**:
- Lasix (not provided)

### Medication management

**Details**: Started on aspirin, given Morphine and Nitroglycerin
**Treatment**: Aspirin, Morphine, Nitroglycerin

**Medications**:
- Aspirin (not provided)
- Morphine (not provided)
- Nitroglycerin (not provided)

### cardiac catheterization

**Details**: Showed three vessel disease

### intra aortic balloon pump placement

**Details**: Placed during catheterization, weaned postoperatively

### coronary artery bypass graft (CABG) x3

**Details**: LIMA to diagonal, saphenous vein graft to RCA and LAD

**Medications**:
- Milrinone (0.25 mcg/kg/min)
- Levofloxacin (0.2 mcg/kg/min)

### speech and swallow evaluation

**Details**: Positive for thin liquids, failed swallow study
**Treatment**: strict aspiration precautions, nasogastric tube placement, tube feeds

### modified barium swallow study

**Details**: Showed moderate oropharyngeal swallow dysfunction
**Treatment**: strict aspiration precautions, thick liquids, tube feeds

### management of atrial fibrillation

**Details**: Lopressor ineffective, loaded with Amiodarone, bradycardic response, pacing required
**Treatment**: Amiodarone, pacing

**Medications**:
- Lopressor (5 mg x4)
- Amiodarone (not provided)

### nutritional support

**Details**: ProMod with fiber to goal of 70 cc/hr, tube feeds, thickened liquids
**Treatment**: tube feeds, thickened liquids

### Physical Therapy

**Details**: Patient received physical therapy during recovery.

### Diet modification

**Details**: Patient placed on pureed and nectar thick liquids, then advanced to renal diet (low potassium).

### Medication management for hyperkalemia

**Details**: Treated with Kayexalate, continuous insulin, D50, and calcium gluconate.

**Medications**:
- Kayexalate (not provided)
- Insulin (continuous)
- D50 (1 amp)
- Calcium gluconate (not provided)

### Medication adjustment for diabetes

**Details**: Sliding scale and hypoglycemic regimen adjusted.
